Detalhe da pesquisa
1.
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness.
Int J Cancer
; 154(10): 1842-1856, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289016
2.
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.
J Cell Physiol
; 227(2): 658-67, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21465472
3.
Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility.
J Cell Physiol
; 225(1): 256-65, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20506359
4.
Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.
J Thorac Oncol
; 11(5): 718-728, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26804638
5.
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab.
Cancer Res
; 74(21): 6248-59, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25164009
6.
The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.
PLoS One
; 6(4): e18727, 2011 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559085